Nanotechnology-based drug delivery for breast cancer treatment: Current applications and future directions

Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology

Zielińska, A., Carreiró, F., Oliveira, A. M., Neves, A., Pires, B., Venkatesh, D. N., Durazzo, A., Lucarini, M., Eder, P., Silva, A. M., et al. (2020) · Molecules · doi:10.3390/molecules25163731 · Cited by 1,560

Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance

Yao, Y., Zhou, Y., Liu, L., Xu, Y., Chen, Q., Wang, Y., Wu, S., Deng, Y., Zhang, J., & Shao, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00193 · Cited by 1,451

Polymeric Nanoparticles for Drug Delivery

Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,279

A Comparative Review of Natural and Synthetic Biopolymer Composite Scaffolds

Reddy, M. S. B., Ponnamma, D., Choudhary, R., & Sadasivuni, K. K. (2021) · Polymers · doi:10.3390/polym13071105 · Cited by 1,104

Smart nanoparticles for cancer therapy

Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073

The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application

Wu, J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080771 · Cited by 1,030

Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages

Mohammadi‐Samani, S., & Ghasemiyeh, P. (2018) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.235156 · Cited by 975

Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery

Shi, L., Zhang, J., Zhao, M., Tang, S., Xu, C., Zhang, W., Li, W., Liu, X., Peng, H., & Wang, Q. (2021) · Nanoscale · doi:10.1039/d1nr02065j · Cited by 843

Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval.

Hwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews · doi:10.1016/j.addr.2020.09.009 · Cited by 699

Breast Cancer—Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature)

Smolarz, B., Nowak, A. Z., & Romanowicz, H. (2022) · Cancers · doi:10.3390/cancers14102569 · Cited by 699

Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment

Subhan, M. A., Yalamarty, S. S. K., Filipczak, N., Parveen, F., & Torchilin, V. P. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060571 · Cited by 623

Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine

Serrano, D. R., Luciano, F. C., Anaya, B. J., Öngoren, B., Kara, A., Molina, G., Ramirez, B. I., Sánchez-Guirales, S. A., Simon, J. A., Tomietto, G., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16101328 · Cited by 594

Lipid Nanoparticles for Drug Delivery

Xu, L., Wang, X., Liu, Y., Yang, G., Falconer, R. J., & Zhao, C. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100109 · Cited by 588

Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review

Viegas, C., Patrício, A. B., Prata, J., Nadhman, A., Chintamaneni, P. K., & Fonte, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061593 · Cited by 585

Natural and Synthetic Polymers for Biomedical and Environmental Applications

Satchanska, G., Davidova, S., & Petrov, P. D. (2024) · Polymers · doi:10.3390/polym16081159 · Cited by 585

Nanomedicine review: clinical developments in liposomal applications

Beltran-Gracia, E., López-Camacho, A., Higuera‐Ciapara, I., Velázquez-Fernández, J. B., & Vallejo‐Cardona, A. A. (2019) · Cancer Nanotechnology · doi:10.1186/s12645-019-0055-y · Cited by 544

To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives

Shi, D., Beasock, D., Fessler, A., Szebeni, J., Ljubimova, J. Y., Afonin, K. A., & Dobrovolskaia, M. A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114079 · Cited by 535

Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers

Roskoski, R. J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.014 · Cited by 502

Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents

Zhou, H., Zhang, J., Zhang, X., & Li, Q. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00430-1 · Cited by 495

New insights into the activities and toxicities of the old anticancer drug doxorubicin

van der Zanden, S. Y., Qiao, X., & Neefjes, J. (2020) · FEBS Journal · doi:10.1111/febs.15583 · Cited by 442

Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer

Singh, R., Pochampally, R. R., Watabe, K., Lü, Z., & Mo, Y. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-256 · Cited by 408

Development of endogenous enzyme-responsive nanomaterials for theranostics

Mu, J., Lin, J., Huang, P., & Chen, X. S. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00663b · Cited by 394

Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery

Majumder, J., & Minko, T. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1828339 · Cited by 353

Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review

Al-Thani, A. N., Jan, A. G., Abbas, M. A. E., Geetha, M., & Sadasivuni, K. K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122899 · Cited by 350

AI-Assisted Detection of Biomarkers by Sensors and Biosensors for Early Diagnosis and Monitoring

Wasilewski, T., Kamysz, W., & Gębicki, J. (2024) · Biosensors · doi:10.3390/bios14070356 · Cited by 328

Paclitaxel: Application in Modern Oncology and Nanomedicine‐Based Cancer Therapy

Sharifi‐Rad, J., Quispe, C., Patra, J. K., Singh, Y. D., Panda, M. K., Das, G., Adetunji, C. O., Michael, O. S., Sytar, O., Polito, L., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3687700 · Cited by 321

Structure‐Based Varieties of Polymeric Nanocarriers and Influences of Their Physicochemical Properties on Drug Delivery Profiles

De, R., Mahata, M. K., & Kim, K. (2022) · Advanced Science · doi:10.1002/advs.202105373 · Cited by 316

Emerging role of exosomes in cancer therapy: progress and challenges

Li, J., Wang, J., & Chen, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02215-4 · Cited by 297

Cancer nanotechnology: current status and perspectives

Kemp, J. A., & Kwon, Y. J. (2021) · Nano Convergence · doi:10.1186/s40580-021-00282-7 · Cited by 290

Advanced Approaches to Breast Cancer Classification and Diagnosis

Zubair, M., Wang, S., & Ali, N. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.632079 · Cited by 285

Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy

Li, J., Liang, H., Liu, J. L., & Wang, Z. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.05.045 · Cited by 284

2D Superparamagnetic Tantalum Carbide Composite MXenes for Efficient Breast-Cancer Theranostics

Liu, Z., Lin, H., Zhao, M., Dai, C., Zhang, S., Peng, W., & Chen, Y. (2018) · Theranostics · doi:10.7150/thno.23369 · Cited by 282

Exosomes: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials

Chen, Y., Luh, F., Ho, Y., & Yen, Y. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01055-0 · Cited by 280

Recent Applications of PLGA in Drug Delivery Systems

Yang, J., Zeng, H., Luo, Y., Chen, Y., Wang, M., Wu, C., & Hu, P. (2024) · Polymers · doi:10.3390/polym16182606 · Cited by 268

Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy

Fu, S., Li, G., Zang, W., Zhou, X., Shi, K., & Zhai, Y. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.08.012 · Cited by 266

Artificial intelligence aids in development of nanomedicines for cancer management

Tan, P., Chen, X., Zhang, H., Wei, Q., & Luo, K. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.01.005 · Cited by 256

Exploring Various Techniques for the Chemical and Biological Synthesis of Polymeric Nanoparticles

Pulingam, T., Foroozandeh, P., Chuah, J., & Sudesh, K. (2022) · Nanomaterials · doi:10.3390/nano12030576 · Cited by 252

Degradable Polymeric Bio(nano)materials and Their Biomedical Applications: A Comprehensive Overview and Recent Updates

Kuperkar, K. C., Atanase, L. I., Bahadur, A., Crivei, I. C., & Bahadur, P. (2024) · Polymers · doi:10.3390/polym16020206 · Cited by 250

Dendrimers in the context of nanomedicine

Dias, A. P., Santos, S. D. S., Silva, J. V., Parise‐Filho, R., Ferreira, E. I., Seoud, O. A. E., & Giarolla, J. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118814 · Cited by 247

Drug Delivery With Carbon-Based Nanomaterials as Versatile Nanocarriers: Progress and Prospects

Debnath, S. K., & Srivastava, R. (2021) · Frontiers in Nanotechnology · doi:10.3389/fnano.2021.644564 · Cited by 244

Progress in Polymeric Micelles for Drug Delivery Applications

Kotta, S., Aldawsari, H. M., Badr-Eldin, S. M., Nair, A. B., & Kamal, Y. T. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081636 · Cited by 241

Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications

Asleh, K., Riaz, N., & Nielsen, T. O. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02476-1 · Cited by 235

Comprehensive analysis of liposome formulation parameters and their influence on encapsulation, stability and drug release in glibenclamide liposomes

Maritim, S., Boulas, P., & Lin, Y. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.120051 · Cited by 232

Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review

Meng, X., Shen, Y., Zhao, H., Lu, X., Wang, Z., & Zhao, Y. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02859-w · Cited by 232

(Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy

Ashrafizadeh, M., Zarrabi, A., Bigham, A., Taheriazam, A., Saghari, Y., Mirzaei, S., Hashemi, M., Hushmandi, K., Karimi‐Maleh, H., Zare‬, E. N., et al. (2023) · Medicinal Research Reviews · doi:10.1002/med.21971 · Cited by 218

Lipid nanoparticle-mediated efficient delivery of CRISPR/Cas9 for tumor therapy

Zhang, L., Wang, P., Feng, Q., Wang, N., Chen, Z., Huang, Y., Zheng, W., & Jiang, X. (2017) · NPG Asia Materials · doi:10.1038/am.2017.185 · Cited by 218

Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges

Zhang, M., Zang, X., Wang, M., Li, Z., Qiao, M., Hu, H., & Chen, D. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00170k · Cited by 216

Curcumin-Loaded Solid Lipid Nanoparticles Enhanced Anticancer Efficiency in Breast Cancer

Wang, W., Chen, T., Xu, H., Ren, B., Cheng, X., Qi, R., Liu, H., Wang, Y., Yan, L., Chen, S., et al. (2018) · Molecules · doi:10.3390/molecules23071578 · Cited by 204

Nanotechnology: A Promising Approach for Cancer Diagnosis, Therapeutics and Theragnosis

Dessale, M., Mengistu, G., & Mengist, H. M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s378074 · Cited by 201

Polymeric micelles and cancer therapy: an ingenious multimodal tumor-targeted drug delivery system

Hari, S. K., Gauba, A., Shrivastava, N., Tripathi, R. M., Jain, S. K., & Pandey, A. K. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01197-4 · Cited by 200

Advances in artificial intelligence for drug delivery and development: A comprehensive review

Gholap, A. D., Uddin, M. J., Faiyazuddin, M., Omri, A., Gowri, S., & Khalid, M. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108702 · Cited by 197

Liposomes containing nanoparticles: preparation and applications

Leo, V. D., Maurelli, A. M., Giotta, L., & Catucci, L. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112737 · Cited by 195

Polymeric nanoparticles—Promising carriers for cancer therapy

Xiao, X., Teng, F., Shi, C., Chen, J., Wu, S., Wang, B., Meng, X., Imeh, A. E., & Li, W. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1024143 · Cited by 193

Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells

da Rocha, M. C. O., da Silva, P. B., Radicchi, M. A., Andrade, B. Y. G., de Oliveira, J. V., Venus, T., Merker, C., Estrela‐Lopis, I., Longo, J. P. F., & Báo, S. N. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00604-7 · Cited by 191

An Updated Review on EPR-Based Solid Tumor Targeting Nanocarriers for Cancer Treatment

Sharifi, M., Cho, W. C. S., Ansariesfahani, A., Tarharoudi, R., Malekisarvar, H., Sari, S., Bloukh, S. H., Edis, Z., Amin, M., Gleghorn, J. P., et al. (2022) · Cancers · doi:10.3390/cancers14122868 · Cited by 191

Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications

Amiri, A., Bagherifar, R., Ansari Dezfouli, E., Kiaie, S. H., Jafari, R., & Ramezani, R. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03325-7 · Cited by 186

Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue

Gote, V., Nookala, A. R., Bolla, P. K., & Pal, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094673 · Cited by 182

Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies

Karim, A. M., Kwon, J. E., Ali, T., Jang, J., Ullah, I., Lee, Y., Park, D. W., Park, J. H., Jeang, J. W., & Kang, S. C. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115545 · Cited by 182

Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells

Nicoletto, R. E., & Ofner, C. M. (2022) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-022-04400-y · Cited by 178

Chitosan on the surface of nanoparticles for enhanced drug delivery: A comprehensive review

Elkomy, M. H., Ali, A. A., & Eid, H. M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.10.005 · Cited by 174

Solid lipid nanoparticles: An effective lipid-based technology for cancer treatment

Akanda, M., Mithu, M. S. H., & Douroumis, D. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104709 · Cited by 167

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation

Cho, H., Jeon, S. I., Ahn, C., Shim, M. K., & Kim, K. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040728 · Cited by 163

Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence

Aramini, B., Masciale, V., Grisendi, G., Bertolini, F., Maur, M., Guaitoli, G., Isca, C., Morandi, U., Stella, F., Dominici, M., et al. (2022) · Cancers · doi:10.3390/cancers14040976 · Cited by 154

Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles

Wang, J., Zhu, M., & Nie, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113974 · Cited by 153

Recent Advances in Exosome-Based Drug Delivery for Cancer Therapy

Kim, H., Jang, H., Cho, H., Choi, J., Hwang, K. Y., Choi, Y., Kim, S. H., & Yang, Y. (2021) · Cancers · doi:10.3390/cancers13174435 · Cited by 152

Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy

Guo, X., Kang, X., Wang, Y.-Q., Zhang, X., Li, C., Yang, L., & Du, L. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.12.007 · Cited by 152

Applications of Dendrimers in Nanomedicine and Drug Delivery: A Review

Nikzamir, M., Hanifehpour, Y., Akbarzadeh, A., & Panahi, Y. (2021) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-021-01925-2 · Cited by 152

The past, present, and future of breast cancer models for nanomedicine development

Boix-Montesinos, P., Soriano‐Teruel, P. M., Armiñán, A., Orzáez, M., & Vicent, M. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.018 · Cited by 146

Emerging Biofabrication Techniques: A Review on Natural Polymers for Biomedical Applications

Puertas‐Bartolomé, M., Mora‐Boza, A., & García‐Fernández, L. (2021) · Polymers · doi:10.3390/polym13081209 · Cited by 144

Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management

Tagde, P., Najda, A., Nagpal, K., Kulkarni, G. T., Shah, M., Ullah, O., Balant, S., & Rahman, M. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052856 · Cited by 144

Recent Advances in Preclinical Research Using PAMAM Dendrimers for Cancer Gene Therapy

Tarach, P., & Janaszewska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062912 · Cited by 141

Novel drug delivery systems based on silver nanoparticles, hyaluronic acid, lipid nanoparticles and liposomes for cancer treatment

Hussein, H. A., & Abdullah, M. A. (2021) · Applied Nanoscience · doi:10.1007/s13204-021-02018-9 · Cited by 141

Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model

Alshaer, W., Hillaireau, H., Vergnaud, J., Mura, S., Deloménie, C., Sauvage, F., Ismail, S. I., & Fattal, E. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.022 · Cited by 140

Lipid-Based Nanocarrier System for the Effective Delivery of Nutraceuticals

Subramanian, P. (2021) · Molecules · doi:10.3390/molecules26185510 · Cited by 140

Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation

González‐Valdivieso, J., Girotti, A., Schneider, J., & Arias, F. J. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120438 · Cited by 138

Quantum Dots: An Emerging Approach for Cancer Therapy

Devi, S., Kumar, M., Tiwari, A., Tiwari, V., Kaushik, D. K., Verma, R., Bhatt, S., Sahoo, B. M., Bhattacharya, T., Alshehri, S., et al. (2022) · Frontiers in Materials · doi:10.3389/fmats.2021.798440 · Cited by 137

Design of pH-Responsive Nanomaterials Based on the Tumor Microenvironment

Liu, Y., Si, L., Jiang, Y., Jiang, S., Zhang, X., Li, S., Chen, J., & Hu, J. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s504629 · Cited by 137

Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment

Isa, E. D. M., Ahmad, H., Rahman, M. B. A., & Gill, M. R. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020152 · Cited by 136

Anticancer Effects of Resveratrol-Loaded Solid Lipid Nanoparticles on Human Breast Cancer Cells

Wang, W., Zhang, L., Chen, T., Guo, W. Z., Bao, X., Wang, D., Ren, B., Wang, H., Li, Y., Wang, Y., et al. (2017) · Molecules · doi:10.3390/molecules22111814 · Cited by 135

Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles

Liu, Y., Zhu, Y., Mao, C., Dou, S., Shen, S., Tan, Z., & Wang, J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.001 · Cited by 134

Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles

Ranjbar, S., Emamjomeh, A., Sharifi, F., Zarepour, A., Aghaabbasi, K., Dehshahri, A., Sepahvand, A. M., Zarrabi, A., Beyzaei, H., Zahedi, M. M., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071944 · Cited by 134

Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer Cells

Abd-Ellatef, G. E. F., Gazzano, E., Chirio, D., Hamed, A. R., Belisario, D. C., Zuddas, C., Peira, E., Rolando, B., Kopecka, J., Marie, M. A. S., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020096 · Cited by 130

Carbon-Based Nanomaterials for Delivery of Biologicals and Therapeutics: A Cutting-Edge Technology

Mahor, A., Singh, P. P., Bharadwaj, P., Sharma, N., Yadav, S., Rosenholm, J. M., & Bansal, K. K. (2021) · C – Journal of Carbon Research · doi:10.3390/c7010019 · Cited by 127

Nanomedicine in treatment of breast cancer – A challenge to conventional therapy

Afzal, M., Zafar, A., Alharbi, K. S., Alruwaili, N. K., Al-Abbasi, F. A., Almalki, A. A., Kazmi, I. A., Kumar, V., Kamal, M. A., Nadeem, M. S., et al. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.016 · Cited by 125

Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo

Zheng, G., Zheng, M., Yang, B., Fu, H., & Li, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109006 · Cited by 124

Formulation and Development of Transferrin Targeted Solid Lipid Nanoparticles for Breast Cancer Therapy

Bhagwat, G. S., Athawale, R., Gude, R. P., Md, S., Alhakamy, N. A., Fahmy, U. A., & Kesharwani, P. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.614290 · Cited by 124

Bio-Based and Biodegradable Polymeric Materials for a Circular Economy

Oliver-Cuenca, V., Salaris, V., Muñoz-Gimena, P. F., Agüero, Á., Peltzer, M. A., Alcázar, V., Arrieta, M. P., Sempere‐Torregrosa, J., Pavón, C., Samper, M. D., et al. (2024) · Polymers · doi:10.3390/polym16213015 · Cited by 123

Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects

Sajjadi, M., Nasrollahzadeh, M., Jaleh, B., Soufi, G. J., & Iravani, S. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1886301 · Cited by 120

Surface Engineering of Nanomaterials with Polymers, Biomolecules, and Small Ligands for Nanomedicine

Diez-Pascual, A. M. (2022) · Materials · doi:10.3390/ma15093251 · Cited by 118

Cost–Effectiveness of Nanomedicine: Estimating the Real Size of Nano-Costs

Bosetti, R., & Jones, S. L. (2019) · Nanomedicine · doi:10.2217/nnm-2019-0130 · Cited by 117

A detailed insight of the tumor targeting using nanocarrier drug delivery system

Batool, S., Sohail, S., Din, F. U., Alamri, A. H., Alqahtani, A. S., Alshahrani, M. A., Alshehri, M. A. S., & Choi, H. G. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2183815 · Cited by 116

Polymeric Micelles for Breast Cancer Therapy: Recent Updates, Clinical Translation and Regulatory Considerations

Junnuthula, V., Kolimi, P., Nyavanandi, D., Sampathi, S., Vora, L. K., & Dyawanapelly, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091860 · Cited by 114

Exploring dendrimer-based drug delivery systems and their potential applications in cancer immunotherapy

Mukherjee, S., Mukherjee, S., Abourehab, M. A. S., Sahebkar, A., & Kesharwani, P. (2022) · European Polymer Journal · doi:10.1016/j.eurpolymj.2022.111471 · Cited by 113

Lyophilization of Nanoparticles, Does It Really Work? Overview of the Current Status and Challenges

Gatto, M. S., & Najahi‐Missaoui, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814041 · Cited by 113

Recent update of toxicity aspects of nanoparticulate systems for drug delivery

Patnaik, S., Gorain, B., Padhi, S., Choudhury, H., Gabr, G. A., Md, S., Mishra, D. K., & Kesharwani, P. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.02.010 · Cited by 112

Optimization of the Conditions of Solid Lipid Nanoparticles (SLN) Synthesis

Musielak, E., Feliczak‐Guzik, A., & Nowak, I. (2022) · Molecules · doi:10.3390/molecules27072202 · Cited by 112

Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy

Peng, X., Fang, J., Lou, C., Yang, L., Shan, S., Wang, Z., Chen, Y., Li, H., & Li, X. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.05.010 · Cited by 111

Resveratrol loaded polymeric micelles for theranostic targeting of breast cancer cells

Gregoriou, Y., Gregoriou, G., Yılmaz, V., Kapnisis, K. K., Prokopi, M., Anayiotos, A. S., Strati, K., Dietis, N., Constantinou, A. I., & Andreou, C. (2020) · Nanotheranostics · doi:10.7150/ntno.51955 · Cited by 110

Cutting-edge approaches for targeted drug delivery in breast cancer: beyond conventional therapies

Chaudhari, R. H., Patel, V., & Kumar, A. (2024) · Nanoscale Advances · doi:10.1039/d4na00086b · Cited by 106

Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer

Niu, S., Zhang, X., Williams, G. R., Wu, J., Gao, F., Fu, Z., Chen, X., Lu, S., & Zhu, L. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.024 · Cited by 106

Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised phase III trial

Schneeweiß, A., Möbus, V. J., Tesch, H., Hanusch, C. A., Denkert, C., Lübbe, K., Huober, J., Klare, P., Kümmel, S., Untch, M., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.10.015 · Cited by 105

Development of fisetin-loaded folate functionalized pluronic micelles for breast cancer targeting

Pawar, A., Singh, S., Rajalakshmi, S., Shaikh, K. S., & Bothiraja, C. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1423991 · Cited by 104

Boosting Degradation of Biodegradable Polymers

Bher, A., Cho, Y., & Auras, R. A. (2023) · Macromolecular Rapid Communications · doi:10.1002/marc.202200769 · Cited by 100

Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer

Rajana, N., Mounika, A., Chary, P. S., Bhavana, V., Anuradha, U., Khatri, D. K., Singh, S. B., & Mehra, N. K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.009 · Cited by 98

Noble Metal Nanoparticle-Based Photothermal Therapy: Development and Application in Effective Cancer Therapy

Yu, S., Xia, G., Yang, N., Yuan, L., Li, J., Wang, Q., Li, D., Ding, L., Fan, Z., & Li, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115632 · Cited by 96

Folic acid receptor-targeted solid lipid nanoparticles to enhance cytotoxicity of letrozole through induction of caspase-3 dependent-apoptosis for breast cancer treatment

Yassemi, A., Kashanian, S., & Zhaleh, H. (2020) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2019.1703739 · Cited by 94

Polymeric Nanoparticles—Tools in a Drug Delivery System in Selected Cancer Therapies

Madej, M., Kurowska, N., & Strzałka‐Mrozik, B. (2022) · Applied Sciences · doi:10.3390/app12199479 · Cited by 94

Recent advances in mesoporous silica nanoparticle: synthesis, drug loading, release mechanisms, and diverse applications

Fatima, R., Katiyar, P., & Kalpana, K. (2025) · Frontiers in Nanotechnology · doi:10.3389/fnano.2025.1564188 · Cited by 94

Associations between persistent organic pollutants and risk of breast cancer metastasis

Koual, M., Cano-Sancho, G., Bats, A., Tomkiewicz, C., Kaddouch-Amar, Y., Douay-Hauser, N., Ngô, C., Bonsang‐Kitzis, H., Deloménie, M., Lecuru, F. R., et al. (2019) · Environment International · doi:10.1016/j.envint.2019.105028 · Cited by 93

Employing nano-enabled artificial intelligence (AI)-based smart technologies for prediction, screening, and detection of cancer

Chugh, V., Basu, A., Kaushik, A. K., Manshu, Bhansali, S., & Basu, A. K. (2024) · Nanoscale · doi:10.1039/d3nr05648a · Cited by 93

Chitosan-coated nanostructured lipid carriers for transdermal delivery of tetrahydrocurcumin for breast cancer therapy

Truong, T. H., Alcantara, K. P., Bulatao, B. P. I., Sorasitthiyanukarn, F. N., Muangnoi, C., Nalinratana, N., Vajragupta, O., Rojsitthisak, P., & Rojsitthisak, P. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119401 · Cited by 91

Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line

Kamel, A. E., Fadel, M., & Louis, D. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s210484 · Cited by 91

Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system

Sun, X., Zhao, P., Lin, J., Chen, K., & Shen, J. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2023.16 · Cited by 90

Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment

Chowdhury, N., Chaudhry, S., Hall, N., Olverson, G., Zhang, Q.-J., Mandal, T. K., Dash, S., & Kundu, A. K. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01743-8 · Cited by 88

Artificial intelligence in nanotechnology for treatment of diseases

Heydari, S., Masoumi, N., Esmaeeli, E., Ayyoubzadeh, S. M., Ghorbani‐Bidkorbeh, F., & Ahmadi, M. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2393417 · Cited by 86

Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer

Valcourt, D. M., Dang, M. N., Scully, M. A., & Day, E. S. (2020) · ACS Nano · doi:10.1021/acsnano.9b09263 · Cited by 85

CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope

Karn, V., Sandhya, S., Hsu, W., Parashar, D., Singh, H. N., Jha, N. K., Gupta, S. K., Dubey, N. K., & Kumar, S. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02654-3 · Cited by 85

The Advancing Role of Nanocomposites in Cancer Diagnosis and Treatment

Andoh, V., Ocansey, D. K. W., Naveed, H., Wang, N., Chen, L., Chen, K., & Mao, F. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s471360 · Cited by 85

Synthesis and evaluation of polyethylene glycol- and folic acid-conjugated polyamidoamine G4 dendrimer as nanocarrier

Narmani, A., Mohammadnejad, J., & Yavari, K. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.01.037 · Cited by 85

Enhanced antitumor and anti-metastasis efficacy against aggressive breast cancer with a fibronectin-targeting liposomal doxorubicin

Jiang, K., Song, X., Yang, L., Li, L., Wan, Z., Sun, X., Gong, T., Lin, Q., & Zhang, Z. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.026 · Cited by 83

Anticancer Potential of Silibinin Loaded Polymeric Nanoparticles against Breast Cancer Cells: Insight into the Apoptotic Genes Targets

Pourgholi, A., Dadashpour, M., Mousapour, A., Amandi, A. F., & Zarghami, N. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.8.2587 · Cited by 83

PAMAM-modified citric acid-coated magnetic nanoparticles as pH sensitive biocompatible carrier against human breast cancer cells

Nosrati, H., Adibtabar, M., Sharafi, A., Danafar, H., & Manjili, H. K. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1451881 · Cited by 83

Prodrug approaches for the development of a long-acting drug delivery systems

Chien, S.-T., Suydam, I. T., & Woodrow, K. A. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114860 · Cited by 81

Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands

Tang, J., Howard, C. B., Mahler, S. M., Thurecht, K. J., Huang, L., & Xu, Z. P. (2018) · Nanoscale · doi:10.1039/c7nr08644j · Cited by 81

Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic

Fraguas‐Sánchez, A. I., Lozza, I., & Torres‐Suárez, A. I. (2022) · Cancers · doi:10.3390/cancers14051198 · Cited by 80

Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells

Xu, W., Bae, E. J., & Lee, M. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s182621 · Cited by 78

Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of curcumin loaded solid lipid nanoparticles for improved anticancer activity

Rompicharla, S. V. K., Bhatt, H., Shah, A., Komanduri, N., Vijayasarathi, D., Ghosh, B., & Biswas, S. (2017) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2017.08.009 · Cited by 75

Mesoporous silica nanoparticles: a smart nanosystem for management of breast cancer

Poonia, N., Lather, V., & Pandita, D. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.10.022 · Cited by 75

Nanoencapsulated Dietary Polyphenols for Cancer Prevention and Treatment: Successes and Challenges

Tabrez, S. S. M., Jabir, N. R., Adhami, V. M., Khan, M. I., Moulay, M., Kamal, M. A., & Mukhtar, H. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0398 · Cited by 75

Toxicity prediction of nanoparticles using machine learning approaches

Ahmadi, M., Ayyoubzadeh, S. M., & Ghorbani-Bidkorpeh, F. (2023) · Toxicology · doi:10.1016/j.tox.2023.153697 · Cited by 75

A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells

Shen, Y., Li, M., Liu, T., Liu, J., Xie, Y., Zhang, J., Xu, S., & Liu, H. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s201688 · Cited by 75

Beta-carotene-Encapsulated Solid Lipid Nanoparticles (BC-SLNs) as Promising Vehicle for Cancer: an Investigative Assessment

Jain, A., Sharma, G., Thakur, K., Raza, K., Shivhare, U. S., Ghoshal, G., & Katare, O. P. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1301-7 · Cited by 75

Chitosan Coated Luteolin Nanostructured Lipid Carriers: Optimization, In Vitro-Ex Vivo Assessments and Cytotoxicity Study in Breast Cancer Cells

Gilani, S. J., Bin-Jumah, M. N., Rizwanullah, M., Imam, S. S., Imtiyaz, K., Alshehri, S., & Rizvi, M. M. A. (2021) · Coatings · doi:10.3390/coatings11020158 · Cited by 70

The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies

Yang, F., He, Q., Dai, X., Zhang, X., & Song, D. E. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1143102 · Cited by 69

Emerging Applications of Nanoparticles in the Diagnosis and Treatment of Breast Cancer

Oehler, J. B., Rajapaksha, W., & Albrecht, H. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14070723 · Cited by 69

Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: Synthesis and biological evaluation

Zhao, Z., Zhao, Y., Xie, C., Chen, C., Lin, D., Wang, S., Lin, D., Cui, X., Guo, Z., & Zhou, J. (2019) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2019.104785 · Cited by 69

Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer

Fu, M., Tang, W., Liu, J., Gong, X., Kong, L., Yao, X., Jing, M. X., Cai, F.-Y., Li, X., & Ju, R.-J. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1656725 · Cited by 69

Trends in Drug Delivery Systems for Natural Bioactive Molecules to Treat Health Disorders: The Importance of Nano-Liposomes

Cardoso, R. V., Pereira, P. R., Freitas, C. S., & Paschoalin, V. M. F. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122808 · Cited by 69

MiR-206 conjugated gold nanoparticle based targeted therapy in breast cancer cells

Chaudhari, R. H., Nasra, S., Meghani, N., & Kumar, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-08185-1 · Cited by 69

Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer

Piccolo, M., Misso, G., Ferraro, M. G., Riccardi, C., Capuozzo, A., Zarone, M. R., Μaione, F., Trifuoggi, M., Stiuso, P., D’Errico, G., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43411-3 · Cited by 68

Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells

Jafari, R., Zolbanin, N. M., Majidi, J., Atyabi, F., Yousefi, M., Jadidi‐Niaragh, F., Maleki, L. A., Shanehbandi, D., Soltani‐Zangbar, M. S., & Rafatpanah, H. (2018) · Iranian Biomedical Journal · doi:10.29252/ibj.23.1.21 · Cited by 68

Exosome-based nanoparticles and cancer immunotherapy

Ye, J., Li, D., Jie, Y., Luo, H., Zhang, W., & Qiu, C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117296 · Cited by 67

Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer

Eskiler, G. G., Çeçener, G., Dıkmen, G., Egelí, Ü., & Tunca, B. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.04.040 · Cited by 67

Microfluidic-mediated nano-drug delivery systems: from fundamentals to fabrication for advanced therapeutic applications.

Ma, Q.-M., Cao, J., Gao, Y., Han, S.-C., Liang, Y., Zhang, T., Wang, X.-Y., & Sun, Y. (2020) · Nanoscale · doi:10.1039/d0nr02397c · Cited by 66

Docetaxel-loaded nanostructured lipid carriers functionalized with trastuzumab (Herceptin) for HER2-positive breast cancer cells

Varshosaz, J., Davoudi, M. A., & Rasoul‐Amini, S. (2017) · Journal of Liposome Research · doi:10.1080/08982104.2017.1370471 · Cited by 66

In-Vitro Application of Magnetic Hybrid Niosomes: Targeted siRNA-Delivery for Enhanced Breast Cancer Therapy

Maurer, V., Altin, S., Seleci, D. A., Zarinwall, A., Temel, B., Vogt, P. M., Strauß, S., Stahl, F., Scheper, T. H., Bucan, V., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030394 · Cited by 65

Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: possible clinical application

Jafari-Gharabaghlou, D., Dadashpour, M., Khanghah, O. J., Salmani-Javan, E., & Zarghami, N. (2023) · Molecular Biology Reports · doi:10.1007/s11033-022-08171-w · Cited by 65

Polymer-lipid hybrid nanoparticles: A novel drug delivery system for enhancing the activity of Psoralen against breast cancer

Du, M., Ouyang, Y., Meng, F., Zhang, X., Ma, Q., Zhuang, Y., Liu, H., Pang, M., Cai, T., & Cai, Y. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.03.006 · Cited by 65

Trastuzumab Targeted Neratinib Loaded Poly-Amidoamine Dendrimer Nanocapsules for Breast Cancer Therapy

Aleanizy, F. S., Alqahtani, F. Y., Setó, S., Khalil, N., Aleshaiwi, L., Alghamdi, M., AlQuadeib, B. T., Alkahtani, H. M., Aldarwesh, A., Alqahtani, Q. H., et al. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s256898 · Cited by 64

Chitosan coated solid lipid nanoparticles as promising carriers for docetaxel

Dawoud, M. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102409 · Cited by 61

Surface-modified lipid-based nanocarriers as a pivotal delivery approach for cancer therapy: application and recent advances in targeted cancer treatment

Anwar, D. M., Hedeya, H. Y., Ghozlan, S. H., Ewas, B. M., & Khattab, S. N. (2024) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-024-00566-x · Cited by 61

Cyclodextrin nanoparticles for diagnosis and potential cancer therapy: A systematic review

Karthic, A., Roy, A., Lakkakula, J., Alghamdi, S. A., Shakoori, A. M., Babalghith, A. O., Emran, T. B., Sharma, R., Lima, C. M. G., Kim, B., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.984311 · Cited by 60

Revolutionizing drug delivery systems: Nanotechnology-based approaches for targeted therapy

Emeihe, E. V., Nwankwo, E. I., Ajegbile, M. D., Olaboye, J. A., & Maha, C. C. (2024) · International Journal of Life Science Research Archive · doi:10.53771/ijlsra.2024.7.1.0060 · Cited by 60

Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers

Kretzmann, J. A., Evans, C. W., Moses, C., Sorolla, A., Kretzmann, A. L., Wang, E., Ho, D., Hackett, M. J., Dessauvagie, B. F., Smith, N. M., et al. (2019) · Chemical Science · doi:10.1039/c9sc01432b · Cited by 59

Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer

Pradhan, R., Dey, A., Taliyan, R., Puri, A., Kharavtekar, S. S., & Dubey, S. K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010246 · Cited by 59

Redefining the importance of polylactide-co-glycolide acid (PLGA) in drug delivery

Chavan, Y. R., Tambe, S. M., Jain, D. D., Khairnar, S. V., & Amin, P. D. (2021) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2021.11.009 · Cited by 58

Stimuli-responsive hydrogel based on natural polymers for breast cancer

Asadi, K., Samiraninezhad, N., Akbarizadeh, A. R., Amini, A., & Gholami, A. (2024) · Frontiers in Chemistry · doi:10.3389/fchem.2024.1325204 · Cited by 58

Design and evaluation of cabazitaxel loaded NLCs against breast cancer cell lines

Chand, P., Kumar, H., Badduri, N., Gupta, N. V., Bettada, V. G., Madhunapantula, S. V., Kesharwani, S. S., Dey, S., & Jain, V. K. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111535 · Cited by 57

A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature

El‐Sahli, S., Hua, K., Sulaiman, A., Chambers, J., Li, L., Farah, E., McGarry, S., Liu, D., Zheng, P., Lee, S. H., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03308-w · Cited by 57

Artificial intelligence-aided optical imaging for cancer theranostics

Xu, M., Chen, Z., Zheng, J., Zhao, Q., & Yuan, Z. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.06.003 · Cited by 57

Chondroitin/Lactoferrin-dual functionalized pterostilbene-solid lipid nanoparticles as targeted breast cancer therapy

Aly, S., El-Kamel, A. H., Sheta, E., & El-Habashy, S. E. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123163 · Cited by 57

Nano-drug Delivery System: a Promising Approach Against Breast Cancer

Malik, J. A., Ansari, J. A., Ahmed, S., Khan, A. A., Ahemad, N., & Anwar, S. (2023) · Therapeutic Delivery · doi:10.4155/tde-2023-0020 · Cited by 57

Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization, in vitro characterization and cell culture studies

Rizwanullah, M., Perwez, A., Mir, S. R., Rizvi, M. M. A., & Amin, S. (2021) · Nanotechnology · doi:10.1088/1361-6528/ac1098 · Cited by 57

Polymeric Nanoparticles: Exploring the Current Drug Development and Therapeutic Insight of Breast Cancer Treatment and Recommendations

Sartaj, A., Qamar, Z., Qizilbash, F. F., Annu, Md, S., Alhakamy, N. A., Baboota, S., & Ali, J. (2021) · Polymers · doi:10.3390/polym13244400 · Cited by 57

Chrysin-loaded folate conjugated PF127-F68 mixed micelles with enhanced oral bioavailability and anticancer activity against human breast cancer cells

Baidya, D., Kushwaha, J., Mahadik, K. R., & Patil, S. S. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1576726 · Cited by 56

Ribociclib Nanostructured Lipid Carrier Aimed for Breast Cancer: Formulation Optimization, Attenuating In Vitro Specification, and In Vivo Scrutinization

Sartaj, A., Annu, Biswas, L., Verma, A. K., Sahoo, P. K., Baboota, S., & Ali, J. (2022) · BioMed Research International · doi:10.1155/2022/6009309 · Cited by 56

Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells

Camorani, S., Tortorella, S., Agnello, L., Spanu, C., d’Argenio, A., Nilo, R., Zannetti, A., Locatelli, E., Fedele, M., Franchini, M. C., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102225 · Cited by 56

Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells

Pindiprolu, S. K. S. S., Chintamaneni, P. K., Krishnamurthy, P. T., & Sri, G. K. R. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1539496 · Cited by 56

Co-Delivery of Letrozole and Cyclophosphamide via Folic Acid-Decorated Nanoniosomes for Breast Cancer Therapy: Synergic Effect, Augmentation of Cytotoxicity, and Apoptosis Gene Expression

Sahrayi, H., Hosseini, E., Karimifard, S., Khayam, N., Meybodi, S. M., Amiri, S., Bourbour, M., Far, B. F., Akbarzadeh, I., Bhia, M., et al. (2021) · Pharmaceuticals · doi:10.3390/ph15010006 · Cited by 55

Triple-Negative Breast Cancer: Molecular Particularities Still a Challenge

Varzaru, V. B., Vlad, T., Popescu, R., Vlad, C. S., Moatar, A. E., & Cobec, I. M. (2024) · Diagnostics · doi:10.3390/diagnostics14171875 · Cited by 55

Mycophenolate co-administration with quercetin via lipid-polymer hybrid nanoparticles for enhanced breast cancer management

Patel, G., Thakur, N. S., Kushwah, V., Patil, M. D., Nile, S. H., Jain, S., Kai, G., & Banerjee, U. C. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102147 · Cited by 55

Reducing Dendrimer Generation and PEG Chain Length Increases Drug Release and Promotes Anticancer Activity of PEGylated Polylysine Dendrimers Conjugated with Doxorubicin via a Cathepsin-Cleavable Peptide Linker

Mehta, D. C., Leong, N. J., McLeod, V. M., Kelly, B. D., Pathak, R., Owen, D. J., Porter, C. J. H., & Kaminskas, L. M. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00581 · Cited by 54

Polymeric nanocapsules as drug carriers for sustained anticancer activity of calcitriol in breast cancer cells

Nicolas, S., Bolzinger, M., Jordheim, L. P., Chevalier, Y., Fessi, H., & Almouazen, E. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.08.022 · Cited by 54

Nanoscale strides: exploring innovative therapies for breast cancer treatment

Mugundhan, S. L., & Mothilal, M. (2024) · RSC Advances · doi:10.1039/d4ra02639j · Cited by 54

Design and characterization of dual responsive mesoporous silica nanoparticles for breast cancer targeted therapy

Bhavsar, D., Patel, V. R., & Sawant, K. K. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105428 · Cited by 53

Ultrasound Triggering of Liposomal Nanodrugs for Cancer Therapy: A Review

Bahutair, W. N., Abuwatfa, W. H., & Husseini, G. A. (2022) · Nanomaterials · doi:10.3390/nano12173051 · Cited by 51

Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple‐negative breast cancer cells

Bressler, E. M., Kim, J., Shmueli, R. B., Mirando, A. C., Bazzazi, H., Lee, E., Popel, A. S., Pandey, N. B., & Green, J. J. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36360 · Cited by 50

Nanostructured lipid carrier potentiated oral delivery of raloxifene for breast cancer treatment

Soni, N. K., Sonali, L., Singh, A., Mangla, B., Neupane, Y. R., & Kohli, K. (2020) · Nanotechnology · doi:10.1088/1361-6528/abaf81 · Cited by 50

Ultrasmall Ag2Te Quantum Dots with Rapid Clearance for Amplified Computed Tomography Imaging and Augmented Photonic Tumor Hyperthermia

Dong, L., Li, W., Yu, L., Sun, L., Chen, Y., & Hong, G. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c12948 · Cited by 50

Lipid-Based Nanocarrier Systems for Drug Delivery: Advances and Applications

Zhao, Y., Li, L., Zhou, E.-F., Wang, J., Wang, Y., Guo, L., & Zhang, X. (2022) · Pharmaceutical Fronts · doi:10.1055/s-0042-1751036 · Cited by 50

Nano-Based Theranostic Platforms for Breast Cancer: A Review of Latest Advancements

Arshad, R., Kiani, M. H., Rahdar, A., Sargazi, S., Barani, M., Shojaei, S., Bilal, M., Kumar, D., & Pandey, S. (2022) · Bioengineering · doi:10.3390/bioengineering9070320 · Cited by 50

Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment

Xie, X., Yue, T., Gu, W., Cheng, W., Li, H., Ren, W., Li, F., & Piao, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102483 · Cited by 50

Engineering exosomes to reshape the immune microenvironment in breast cancer: Molecular insights and therapeutic opportunities

Cao, J., Lv, G., & Wei, F. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1645 · Cited by 50

Effects of Curcumin-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles in MDA-MB231 Human Breast Cancer Cells

Sharma, A., Hawthorne, S. J., Jha, S. K., Jha, N. K., Kumar, D., Samuel, G., Goswami, V. K., Gupta, G., Singh, S. K., Dureja, H., et al. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0066 · Cited by 50

Delivery of quercetin for breast cancer and targeting potentiation via hyaluronic nano-micelles

Sun, J., Li, M., Lin, K., Liu, Z., Wang, Z., Wang, W., Zhao, Y., Zhen, Y., & Zhang, S. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124736 · Cited by 50

Nanomedicine-Based Drug-Targeting in Breast Cancer: Pharmacokinetics, Clinical Progress, and Challenges

Rahman, M., Afzal, O., Ullah, S. N. M. N., Alshahrani, M. Y., Alkhathami, A. G., Altamimi, A. S. A., Almujri, S. S., Almalki, W. H., Shorog, E., Alossaimi, M. A., et al. (2023) · ACS Omega · doi:10.1021/acsomega.3c07345 · Cited by 49

Effect of surface ligand modification on the properties of anti-tumor nanocarrier

Ying, N., Lin, X., Xie, M., & Zeng, D. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112944 · Cited by 49

A novel preparative method for nanoparticle albumin-bound paclitaxel with high drug loading and its evaluation both in vitro and in vivo

Gao, Y., Nai, J., Yang, Z., Zhang, J., Ma, S., Zhao, Y., Li, H., Li, J., Yang, Y., Yang, M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250670 · Cited by 48

A journey through the history of PEGylated drug delivery nanocarriers

López-Estévez, A. M., Gref, R., & Alonso, M. J. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01608-8 · Cited by 48

From Passive Targeting to Personalized Nanomedicine: Multidimensional Insights on Nanoparticles’ Interaction with the Tumor Microenvironment

Sebak, A. A., El-Shenawy, B. M., Elsafy, S., & El‐Shazly, M. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666201211103856 · Cited by 48

Gene Therapy with Chitosan Nanoparticles: Modern Formulation Strategies for Enhancing Cancer Cell Transfection

Antoniou, V., Mourelatou, E. A., Galatou, E., Avgoustakis, K., & Hatziantoniou, S. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070868 · Cited by 47

Multimodal Polysilsesquioxane Nanoparticles for Combinatorial Therapy and Gene Delivery in Triple-Negative Breast Cancer

Juneja, R., Lyles, Z., Vadarevu, H., Afonin, K. A., & Vivero-Escoto, J. L. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b00704 · Cited by 46

Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance

Kaushik, L., Srivastava, S., Panjeta, A., Chaudhari, D., Ghadi, R., Kuche, K., Malik, R., Preet, S., Jain, S., & Raza, K. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119088 · Cited by 46

Novel combination of multi-walled carbon nanotubes and gold nanocomposite for photothermal therapy in human breast cancer model

Mohammed, S. N., Mohammed, A. M., & Al-Rawi, K. F. (2022) · Steroids · doi:10.1016/j.steroids.2022.109091 · Cited by 46

Hyaluronic acid-coated single-walled carbon nanotubes loaded with doxorubicin for the treatment of breast cancer

Liu, D., Zhang, Q., Wang, J., Li, F., Zhu, W., & Cai, D. (2019) · Die Pharmazie · doi:10.31083/2019.8152 · Cited by 45

Solid lipid nanoparticles of Annona muricata fruit extract: formulation, optimization and in vitro cytotoxicity studies

Sabapathi, M. L., Palei, N. N., Ck, A. K., & Molakpogu, R. B. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1569027 · Cited by 44

Aptamer-protamine-siRNA nanoparticles in targeted therapy of ErbB3 positive breast cancer cells

Xu, X. S., Li, L., Li, X., Tao, D., Zhang, P., & Gong, J. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119963 · Cited by 43

PEGylated N-(2 hydroxypropyl) methacrylamide polymeric micelles as nanocarriers for the delivery of doxorubicin in breast cancer

Bobde, Y., Patel, T. K., Paul, M., Biswas, S., & Ghosh, B. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.111833 · Cited by 43

Recent advances on chitosan/hyaluronic acid-based stimuli-responsive hydrogels and composites for cancer treatment: A comprehensive review

Alsaikhan, F., & Farhood, B. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135893 · Cited by 43

Co-delivery of siRNA and lycopene encapsulated hybrid lipid nanoparticles for dual silencing of insulin-like growth factor 1 receptor in MCF-7 breast cancer cell line

Mennati, A., Rostamizadeh, K., Manjili, H. K., Fathi, M., & Danafar, H. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.12.197 · Cited by 43

Breast Cancer: Molecular Pathogenesis and Targeted Therapy

Samad, M. A., Ahmad, I., Khan, M. R., Suhail, M., Zughaibi, T. A., Al-Abbasi, F. A., Alhosaini, K. A., Khan, M. S., Kumer, A., & Tabrez, S. S. M. (2025) · MedComm · doi:10.1002/mco2.70404 · Cited by 28

pH-Responsive Delivery of 6-Mercaptopurine-Loaded Hollow Mesoporous Silica Nanoparticles for Breast Cancer Therapy

Krishnan, A., & Francis, M. A. (2025) · BioNanoScience · doi:10.1007/s12668-025-02237-2 · Cited by 12

Natural-Based Magnetite/Hydroxyapatite/Chitosan Nanocomposite as Effective Drug Delivery Systems

Utami, R., Habani, M. H., Sunaryono, S., Munasir, M., Sani, N. S., Yustanti, E., Tahir, D., & Taufiq, A. (2025) · Journal of Cluster Science · doi:10.1007/s10876-025-02861-8 · Cited by 9

Radiopaque Silk Sericin Nanoparticles for Computed Tomography Imaging of Solid Tumors

Bhoopathy, J., Vedakumari, S. W., Pravin, Y. R., & Prabhu, A. D. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00230 · Cited by 8

Targeted Drug Delivery with Nanosponges and Nanocrystals: Innovations, Formulation Strategies, and Applications

Aneja, P., Guleria, R., & Dahiya, D. P. (2025) · Assay and Drug Development Technologies · doi:10.1089/adt.2025.026 · Cited by 6

Nanotechnology-based Therapeutic Strategies for Breast Cancer

Aljadani, M. (2022) · International Journal of Pharmaceutical Investigation · doi:10.5530/ijpi.2022.2.27 · Cited by 3

Nanotechnology based targeted drug delivery systems for breast cancer: challenges, recent advancement and future perspectives

Kumar, S., Rathaur, S., Maity, D., Varshney, P., & Gayen, J. R. (2026) · Nanomedicine · doi:10.1080/17435889.2026.2637591 · Cited by 6

Intelligent nano‐platforms in breast cancer therapy: Current advances and future perspectives

Rahimi, T., & Aivazi, M. (2026) · Precision Medical Sciences · doi:10.1002/prm2.70023

Beyond Conventional Approaches: The Revolutionary Role of Nanoparticles in Breast Cancer

Liu, M., Wang, Y., Li, Y., Zhang, Y., Zhou, B., Yang, L., Yan, X., & Yang, L. (2025) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.70012 · Cited by 3

Nanotechnology-based Approaches for Breast Cancer

Prabha, S., Panda, P. K., Singh, S., & Ahmed, B. (2024) · Current Cancer Therapy Reviews · doi:10.2174/0115733947282469240212075845 · Cited by 2